Clinical Trial Update: Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses [Phase 2]

View source ↗

Summary

Phase 2 study evaluating two antiviral treatment relief strategies for safety and HBV virological control over 96 weeks in HIV/HBV co-infected patients; not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV Infections, HBV Coinfection | Phase 2 | Status: NOT_YET_RECRUITING